New female “condom” to be trialledBMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7250.1626/c (Published 17 June 2000) Cite this as: BMJ 2000;320:1626
- David Spurgeon
Scientists at Laval University in Quebec, Canada, have received $C350 000 (£157 000; $236 000) in federal funds to undertake phase I trials of a new “invisible condom” for women that they have developed over the past nine years.
It consists of a microbiocide gel introduced in liquid form into a woman's vagina, which first acts as a physical barrier to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial